Details of the Drug Reposition

General Information of This Drug (ID: DMG8K57)

Drug Name
Cortisone Acetate   DMG8K57
Synonyms Cortone
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
42 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Serum sickness DIS0MRKJ N.A. Approved [1]
Rheumatic heart disease DISCI8JQ N.A. Approved [1]
Primary cutaneous T-cell lymphoma DIS35WVW N.A. Approved [1]
Miliary tuberculosis DIS4AT5W N.A. Approved [1]
Malignant otitis externa caused by Pseudomonas aeruginosa DIS5C8KP N.A. Approved [1]
Keratitis DISMFOEI N.A. Approved [1]
Granuloma annulare DISMOUMI N.A. Approved [1]
Gingival disorder DISD5M1D N.A. Approved [1]
Exanthem DISAFOQN N.A. Approved [1]
Erythema multiforme DISKCLM1 N.A. Approved [1]
Epicondylitis DIS0R2VM N.A. Approved [1]
Disorder of orbital region DISH0ECJ N.A. Approved [1]
Diamond-Blackfan anemia DISI2SNW N.A. Approved [1]
Bursitis DISCF7Y9 N.A. Approved [1]
Blepharoconjunctivitis DIS4PG4J N.A. Approved [1]
Aspiration pneumonitis DIS5S4DE N.A. Approved [1]
Acute adrenal insufficiency DIS66YLV N.A. Approved [1]
Tinea cruris DIS5JC14 1F28.3 Approved [1]
Advanced cancer DISAT1Z9 2A00-2F9Z Approved [1]
Mycosis fungoides DIS62RB8 2B01 Approved [1]
Autoimmune haemolytic anaemia DIS7MS3M 3A20 Approved [1]
Angioedema DIS90QDN 4A00.15 Approved [1]
Systemic lupus erythematosus DISI1SZ7 4A40.0 Approved [1]
Sarcoidosis DISE5B8Z 4B20.5 Approved [1]
Congenital adrenal hyperplasia DISG873W 5A71.01 Approved [1]
Addison disease DIS7HNOH 5A74.0 Approved [1]
Multiple sclerosis DISB2WZI 8A40 Approved [1]
Cerebral edema DIS4GHSB 8D60.1 Approved [1]
Corneal ulcer DIS8YN8N 9A76 Approved [1]
Allergic rhinitis DIS3U9HN CA08.0 Approved [1]
Severe asthma DISAVQI3 CA23 Approved [1]
Proctitis DIS3K8ZM DB33.Z Approved [1]
Crohn disease DIS2C5Q8 DD70 Approved [1]
Ulcerative colitis DIS8K27O DD71 Approved [1]
Inflammatory bowel disease DISGN23E DD72 Approved [1]
Skin disease DISDW8R6 EA00-EM0Z Approved [1]
Psoriasis DIS59VMN EA90 Approved [1]
Dermatitis herpetiformis DIS0TC0G EB44 Approved [1]
Acne vulgaris DISKW8PI ED80 Approved [1]
Rosacea DIS02PWG ED90.0 Approved [1]
Psoriatic arthritis DISLWTG2 FA21 Approved [1]
Corneal abrasion DIS3SD7J NA06.4 Approved [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 42 Indications(s)
2 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pemphigus DISZAZ6M N.A. Withdrawn [2]
Allergic conjunctivitis DISZ5ZJN 9A60.02 Withdrawn [3]
------------------------------------------------------------------------------------
7 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Tendinitis DISS7ANY N.A. Discontinued in Phase 3 [4]
Thyroiditis DISTCV24 N.A. Discontinued in Phase 3 [5]
Nephrotic syndrome DISSPSC2 N.A. Discontinued in Phase 3 [6]
Anterior uveitis DISQ7EAD 9A96 Discontinued in Phase 3 [7]
Otitis externa DISYCORK AA00-AA13 Discontinued in Phase 3 [8]
Contact dermatitis DISQ3AU0 EK0Z Discontinued in Phase 3 [9]
Ankylosing spondylitis DISRC6IR FA92.0 Discontinued in Phase 3 [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Indications(s)
8 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Iritis DISSA7AC N.A. Discontinued in Phase 2 [11]
Aphthous stomatitis DISR2T25 N.A. Discontinued in Phase 2 [12]
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Discontinued in Phase 2 [13]
Hemorrhoids DISQ5G6G DB60 Discontinued in Phase 2 [14]
Dermatitis DISY5SZC EA80-EA89 Discontinued in Phase 2 [15]
Seborrhoeic dermatitis DISNWVJU EA81 Discontinued in Phase 2 [16]
Musculoskeletal disorder DISPPN0O FA00-FC0Z Discontinued in Phase 2 [17]
Arthritis DIST1YEL FA20 Discontinued in Phase 2 [18]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Indications(s)
4 Discontinued in Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Exfoliative dermatitis DISQEWIW N.A. Discontinued in Phase 1 [19]
Tenosynovitis DISR5H9R N.A. Discontinued in Phase 1 [20]
Humoral hypercalcemia of malignancy DISQQ62D N.A. Discontinued in Phase 1 [21]
Autoimmune disease DISORMTM 4A40-4A45 Discontinued in Phase 1 [22]
------------------------------------------------------------------------------------
7 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Trichinellosis DISUR2ZW N.A. Investigative [1]
Synovitis DISW2GPY N.A. Investigative [1]
Iridocyclitis DISV6UP4 N.A. Investigative [1]
Classic Hodgkin lymphoma DISV1LU6 N.A. Investigative [1]
Beta-thalassemia major DISW06BV N.A. Investigative [1]
Acquired thrombocytopenia DISXH01C N.A. Investigative [1]
Follicular lymphoma DISVEUR6 2A80 Investigative [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Indications(s)

References

1 Cortisone acetate FDA Label
2 Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.
3 Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
4 Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
5 A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea
6 Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients
7 TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )
8 Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
9 Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis
10 Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)
11 Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer
12 A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
13 Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
14 Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
15 Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma
16 The Antidepressant Efficacy of the Anticholinergic Scopolamine
17 Sunitinib in Treating Patients With Idiopathic Myelofibrosis
18 Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy
19 ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
20 Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)
21 Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
22 Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy